Systematic review and meta-analysis reports 36.6% cognitive impairment prevalence in coronary heart disease patients
This systematic review and meta-analysis examines the prevalence of cognitive impairment and associated risk factors among patients with coronary heart disease. The analysis included data from 9,207 patients to determine the overall burden of cognitive dysfunction in this population.
The primary outcome showed a pooled prevalence of cognitive impairment at 36.6% (95% CI 27.6%–45.7%). Several specific risk factors were evaluated to understand their contribution to cognitive decline in these patients.
Age was identified as a risk factor with an odds ratio of 1.10 (95% CI 1.04–1.17, P = 0.001). A history of stroke was associated with an odds ratio of 1.99 (95% CI 1.09–3.62, P = 0.02). Smoking showed the strongest association with an odds ratio of 3.05 (95% CI 2.00–4.66, P = value not reported).
The review did not report adverse events, discontinuations, or tolerability data. Because the study synthesizes observational data, causal language is avoided. The findings provide a reference for the implementation of targeted interventions but require cautious interpretation regarding clinical management.